Real-world monitoring of platelet counts among patients with epithelial ovarian cancer receiving first-line maintenance niraparib in the United States: the ACTIV1ZE study

被引：0
|
作者：
Musa, Fernanda [1 ]
Boyle, Tirza [2 ]
Lim, Jonathan [2 ]
Moore, Julia [2 ]
Schilder, Jeanne [3 ]
Hurteau, Jean [4 ]
Golembesky, Amanda [5 ]
Landrum, Lisa [6 ]
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] GSK, Upper Providence, PA USA
[3] GSK, Philadelphia, PA USA
[4] GSK, Waltham, MA USA
[5] GSK, Durham, NC USA
[6] Indiana Univ, Hlth Simon Canc Ctr, Indianapolis, IN USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.74
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR032/#594
引用
收藏
页码：A56 / A57
页数：2
相关论文
共 50 条
  • [41] Real-world clinical outcomes of patients with de novo advanced high-grade epithelial ovarian cancer eligible to niraparib maintenance in France
    Rodrigues, M.
    Joly, F.
    Ray-Coquard, I. L.
    Costaz, H.
    Classe, J-M.
    Floquet, A.
    Rouge, T. De la Motte
    Colombo, P-E.
    Gross, M. Provansal
    Leblanc, E.
    Pomel, C.
    Marchal, F.
    Barranger, E.
    Savoye, A. M.
    Guillemet, C.
    Petit, T.
    Pautier, P.
    Rouzier, R.
    Courtinard, C.
    Gladieff, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S741 - S742
  • [42] First-line treatment in older patients with metastatic colorectal cancer: A large real-world study
    Basile, D.
    Bergamo, F.
    Ongaro, E.
    Cinausero, M.
    Conca, V.
    Ambrosini, M.
    Lucchetti, J.
    Rosati, G.
    Avallone, A.
    Di Paolo, G.
    Lai, E.
    Lutrino, E. S.
    Di Nardo, P.
    Zurlo, I. V.
    Cortese, C.
    Carullo, M.
    Leo, S.
    Di Donato, S.
    Pietrantonio, F.
    Aprile, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S447 - S447
  • [43] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES WITH FIRST-LINE MAINTENANCE OLAPARIB FOR BRCAM ADVANCED OVARIAN CANCER: A PAN-EUROPEAN STUDY (OVAL-1)
    Gourley, C.
    Asselain, B.
    Garbay, D.
    Lorusso, D.
    Miller, R.
    Condon, O.
    Kertous, M.
    Padrone, C.
    Rigney, U.
    Dube, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A204 - A205
  • [44] A real-world, patient-reported outcomes study in patients with platinum-sensitive recurrent ovarian cancer receiving long-term maintenance therapy with niraparib
    Peng, Peng
    Liu, Tianmou
    Wang, Danbo
    Wang, Yue
    Cheng, Ninghai
    Yao, Liangqing
    Sun, Yang
    Li, Jundong
    Zhang, Hui
    Lou, Ge
    Tang, Jie
    Cao, Dongyan
    Zhang, Guonan
    Xiang, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] An emulated target trial case study of real-world overall survival in second-line maintenance niraparib versus active surveillance in patients with recurrent ovarian cancer
    Perhanidis, Jessica
    Zimmerman, Nicole M.
    Golembesky, Amanda
    Kalilani, Linda
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 426 - 427
  • [46] An Emulated Target Trial Case Study of Real-World Overall Survival With Second-Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer
    Perhanidis, Jessica A.
    Kalilani, Linda
    Zimmerman, Nicole M.
    Golembesky, Amanda
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (09)
  • [47] Real-world effectiveness of first-line maintenance olaparib in women with BRCA-mutated advanced ovarian cancer: US retrospective cohort study.
    Eskander, Ramez Nassef
    Alam, Naufil
    Long, Grainne H.
    Ozgoren, Ozan
    Ambler, Will
    Volpe, Stephanie
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients
    Berton, Dominique
    Floquet, Anne
    Lescaut, Willy
    Baron, Gabriel
    Kaminsky, Marie-Christine
    Toussaint, Philippe
    Largillier, Remy
    Savoye, Aude-Marie
    Alexandre, Jerome
    Delbaldo, Catherine
    Malaurie, Emmanuelle
    Barletta, Hugues
    Bosacki, Claire
    Garnier-Tixidre, Claire
    Follana, Philippe
    Laharie-Mineur, Hortense
    Levache, Charles Briac
    Valenza, Bruno
    Dechartres, Agnes
    Mollon-Grange, Delphine
    Selle, Frederic
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Investigating reasons for discontinuation of first-line adjuvant chemotherapy among ovarian cancer patients in the midwestern United States.
    Weeks, Kristin S.
    Stewart, Sherri L.
    West, Michele
    Carnahan, Ryan
    Oleson, Jacob
    Lynch, Charles F.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345